International Bladder Cancer Group Consensus Statement on Clinical Trial Design for Patients with Bacillus Calmette-Guérin–exposed High-risk Non–muscle-invasive Bladder CancerM. Roumiguié, Peter C. Black, Trinity J. Bivalacqua et al.|European Urology|2021Cited by 94